Human serum stimulates alzheimer markers in cultured hippocampal neurons
- 1 November 1992
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 33 (3) , 355-369
- https://doi.org/10.1002/jnr.490330302
Abstract
The mechanism for promoting the distinct types of lesions in the Alzheimer disease (AD) brain and other changes outside the brain is unknown. We examined neurons in culture, unprotected by glia or a blood-brain barrier, to determine if exposure to serum from Alzheimer patients would affect markers for Alzheimer brain lesions. Rat hippocampal neurons were first grown for 4 days in a new serum-free culture medium, then exposed for 24 hr to human sera. Sera from 12 AD patients or their spouses increased four molecular markers characteristic of Alzheimer senile plaques and neurofibrillary tangles: Alz-50, β-amyloid (β/A4), MAP2, and ubiquitin, each with their expected cytologic distributions. Sera from ten young adults produced significantly less stimulation. By quantitative immunofluorescence, neuronal exposure to the elderly human sera produced 1.8- to 2.5-fold increases in mean fluorescent area/cell for each of these four markers relative to no serum exposure. As controls, an unrelated neuronal marker, enolase, was unaffected and fetal bovine serum did not stimulate immunoreactivity. Neuron viability and somal area were unaffected at 24 hours. The MAP2 increases were dose dependent with negligible effect at 2% serum and maximum effect at 10% serum after 24 hr. The MAP2 increase was greater after 48 hr of exposure than 24 hr and negligible at 2 hr. This stimulation of AD markers by human serum suggests that the genesis of both neuronal plaques and tangles may arise from access of toxic serum factors to susceptible neurons and/or failure to detoxify these factors. © Wiley-Liss, Inc.Keywords
This publication has 81 references indexed in Scilit:
- Microtubular reorganization and dendritic growth response in alzheimer's diseaseAnnals of Neurology, 1989
- Neurotrophic agents may exacerbate the pathologic cascade of Alzheimer's diseaseNeurobiology of Aging, 1989
- A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tanglesNeuroscience Letters, 1989
- Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's DiseaseNew England Journal of Medicine, 1989
- Complement activation in amyloid plaques in Alzheimer’s dementiaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1988
- The survival of dentate gyrus neurons in dissociated cultureDevelopmental Brain Research, 1987
- Glial fibrillary acidic protein and Alzheimer's diseaseNeurochemical Research, 1985
- Alzheimer's Disease: Does Neuron Plasticity Predispose to Axonal Neurofibrillary Degeneration?New England Journal of Medicine, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984